benzoxazoles has been researched along with Multiple Organ Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ancellin, N; Baily, JE; Beaufils, B; Bénéton, V; Binnie, M; Garden, OJ; Haslam, C; Holmes, DS; Homer, NZ; Howie, SE; Hughes, J; Hutchinson, JP; Iredale, JP; Liddle, J; McBride, A; Mirguet, O; Mole, DJ; Mowat, CG; Rowland, P; Sharp, MG; Trottet, L; Uings, I; Walker, A; Webster, SP; Wilkinson, M; Wilson, K; Zheng, X | 1 |
Ray, K | 1 |
2 other study(ies) available for benzoxazoles and Multiple Organ Failure
Article | Year |
---|---|
Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.
Topics: Acute Disease; Animals; Benzoxazoles; Chromatography, Liquid; Crystallography, X-Ray; Disease Models, Animal; HEK293 Cells; Hepatocytes; Humans; In Vitro Techniques; Kidney; Kynurenine 3-Monooxygenase; Lung; Mice; Mice, Knockout; Multiple Organ Failure; Oxazolidinones; Pancreas; Pancreatitis; Propionates; Rats; RNA, Messenger; Tandem Mass Spectrometry; Tryptophan | 2016 |
Pancreatitis: KMO inhibitor for multi-organ failure in experimental acute pancreatitis.
Topics: Animals; Benzoxazoles; Humans; Kynurenine 3-Monooxygenase; Multiple Organ Failure; Oxazolidinones; Pancreatitis; Propionates; RNA, Messenger | 2016 |